ChartMill assigns a Buy % Consensus number of 83% to MBOT. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-03 | Roth Capital | Initiate | Buy |
| 2025-11-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-06 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-09 | HC Wainwright & Co. | Maintains | Buy |
8 analysts have analysed MBOT and the average price target is 7.65 USD. This implies a price increase of 255.81% is expected in the next year compared to the current price of 2.15.
The consensus rating for MICROBOT MEDICAL INC (MBOT) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.